Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures

New England Journal of Medicine

Volumn 326, Issue 23, 1992, Pages 1533-1539

  Koutsky, Laura A ^a   Stevens, Claire E ^a   Holmes, King K ^a   Ashley, Rhoda L ^a   Kiviat, Nancy B ^a   Critchlow, Cathy W ^a   Corey, Lawrence ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COLPOSCOPY; FEMALE; GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; VIRUS CULTURE; VIRUS ISOLATION;

EID: 0026724898     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199206043262305     Document Type: Article

References (38)

1. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98: 958–72
2. Corey L, Holmes KK. Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med 1983; 98: 973–83
3. Guinan ME, MacCalman J, Kern ER, Overall JC Jr, Spruance SL. The course of untreated recurrent genital herpes simplex infection in 27 women. N Engl J Med 1981; 304: 759–63
4. Kaufman RH, Gardner HL, Rawls WE, Dixon RE, Young RL. Clinical features of herpes genitalis. Cancer Res 1973; 33: 1446–51
5. Mertz GJ, Schmidt O, Jourden JL, et al. Frequency of acquisition of firstepisode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985; 12: 33–9
6. Rooney JJ, Felser JM, Ostrove JM, Straus SE. Acquisition of genital herpes from an asymptomatic sexual partner. N Engl J Med 1986; 314: 1561–4
7. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116: 197–202
8. Peterson EP, Schmidt OW, Goldstein LC, Nowinski RC, Corey L. Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA. J Clin Microbiol 1983; 17: 92–6
9. Lynch PJ, Welsh O, Naylor B. Cytodiagnosis of vesicular viral lesions —modified Papanicolaou stain forherpesvirus infections. Cutis 1970; 6: 79–84
10. Papanicolaou GN. Atlas of exfoliative cytology. Cambridge, Mass.: Harvard University Press, 1963:3–12
11. Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRouen T, Holmes KK. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 1988; 158: 819–28
12. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26: 662–7
13. Ashley RL, Militoni J. Use of densitometric analysis for interpreting HSV serologies based on Western blot. J Virol Methods 1987; 18: 159–68
14. Ashley R, Benedetti J, Corey L. Humoral immune responses to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes. J Med Virol 1985; 17: 153–66
15. Ashley R, Cent A, Maggs V, Nahmias A, Corey L. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann Intern Med 1991; 115: 520–6
16. Washington State/Seattle King County HIV/AIDS Quarterly Epidemiology Report: 3rd quarter — 1991. Seattle: Seattle–King County Department of Public Health and Washington State Department of Health, 1991
17. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley, 1981:51–65
18. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case–control studies. Lyon, France: International Agency for Research on Cancer, 1980:192–246. (IARC scientific publications no. 32.)
19. Koutsky LA, Ashley RL, Holmes KK, et al. The frequency of unrecognized type 2 herpes simplex virus infection among women: implications for the control of genital herpes. Sex Transm Dis 1990; 17: 90–4
20. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989; 321: 7–12
21. Guinan ME, Wolinsky SM, Reichman RC. Epidemiology of genital herpes simplex virus infection. Epidemiol Rev 1985; 7: 127–46
22. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990; 69: 19–36
23. Holmberg SB, Stewart JA, Gerber AR, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259: 1048–50
24. Mann SL, Meyers JD, Holmes KL. Corey L. Prevalence and incidence of herpesvirus infections among homosexually active men. J Infect Dis 1984; 149: 1026–7
25. Hardy DA, Arvin AM, Yasukawa LL, et al. Use of polymerase chain reaction for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women at delivery. J Infect Dis 1990; 162: 1031–5
26. Cone RW, Hobson achéal, Palmer J, Remington M, Corey L. Extended duration of herpes simplex DNA in genital lesions detected by the polymerase chain reaction. J Infect Dis 1991; 164: 757–60
27. Lafferty WE, Krofft S, Remington M, et al. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population. J Clin Microbiol 1987; 25: 323–6
28. Dorsky DI, Crumpacker CS. Drugs 5 years later: acyclovir. Ann Intern Med 1987; 107: 859–74
29. Mertz GL, Critchlow CW, Benedetti J, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 1984; 242: 1147–51
30. Bryson YJ, Dillon M, Lovett M. et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir: a randomized double-blind controlled trial in normal subjects. N Engl J Med 1983; 308: 916–21
31. Langenberg A, Benedetti J. Jenkins J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having “asymptomatic” herpes simplex virus type 2 infection. Ann Intern Med 1989; 110: 882–7
32. Mertz GJ, Coombs RW, Ashley R, et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 1988; 157: 1169–77
33. Whitley RJ, Nahmias AJ, Visintine AM, Fleming CL, Alford CA Jr. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980; 66: 489–94
34. Brown ZA, Benedetti J, Ashley R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991; 324: 1247–52
35. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection: influence of site of infection and viral type. N Engl J Med 1987; 316: 1444–9
36. Bader C, Crumpacker CS, Schnipper LE, et al. The natural history of recurrent facial-oral infection with herpes simplex virus. J Infect Dis 1978; 138: 897–905
37. Wade JC, Day LM, Crowley JJ, Meyers JD. Recurrent infection with herpes simplex virus after marrow transplantation: role of specific immune response and acyclovir therapy. J Infect Dis 1984; 149: 750–6
38. Lipson SM, Schutzbank TE, Szabo K. Evaluation of three immunofluorescence assays for culture confirmation and typing of herpes simplex virus. J Clin Microbiol 1987; 25: 391–4